Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Smooth Drug Development Selects CRO Starter Kit™ CTMS by Flex Databases

Published: Monday, September 23, 2013
Last Updated: Monday, September 23, 2013
Bookmark and Share
Flex Databases to release an electronic data capture (EDC) product in Q4 2013.

Flex Databases has announced that Smooth Drug Development has selected Flex CRO Starter Kit™ as its CTMS solution.

Smooth Drug Development is a full-service CRO headquartered in St. Petersburg, Russia. Smooth performs phase I-IV studies and runs 2 phase I units in St. Petersburg.

"We looked at a number of solutions on the market", said Dmitry Morozovsky, CEO of Smooth Drug Development. "In Flex Databases we found a solution which gives us the breadth of functionality we have not seen before, as Flex provide both PSA (such as timesheets, budgets, planning, utilization) and clinical research tools on the same platform. What especially caught our attention is the fact that Flex Databases are going to be releasing an electronic data capture (EDC) product in Q4 2013. We run a lot of bioequivalence studies, where operational efficiency is crucial, and having a single platform bringing together resource management, CTMS and EDC will allow us to shorten study timelines and further improve performance on the studies we run."

"Smooth Drug Development are a forward looking dynamic company who were quick to see the value of our platform", said Timur Galimov, Technical Director at Flex Databases.

Galimov continued, "We come across a lot of interest towards our upcoming EDC product, and we are pleased to have found an early adopter of our EDC technology even before the product has been released. Smooth Drug Development have one of the most comprehensive offerings we have seen in clinical research, and we are keen to help them grow by offering a platform which will streamline all the processes of their business".


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Flex Databases Launches New Web Site
New website cements the company's unique positioning as a PSA company.
Tuesday, March 25, 2014
Scientific News
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
Treatment of Common Prostate Cancer
Researchers at UTSW have found that the prostate cancer treatments suppress immune response and may promote relapse.
Cancer Drug Could Treat Blood Vessel Deformities
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin.
Structure of Crucial Enzyme Identified
Researchers at UTSW have determined the atomic structure of an enzyme that plays an essential role in cell division and better treatment of cancer.
New Immunotherapy Trial for Type 1 Diabetes
The search for a treatment for Type 1 diabetes (T1D) - which affects over 400,000 people in the UK – will be stepped up with the start of a new phase one clinical trial at Guy’s Hospital in London.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!